NeuroMetrix unveils over-the-counter pain product as it opens new Woburn site
On Sunday, Waltham-based NeuroMetrix will unveil the new consumer model of its wearable pain-relief device as the company looks forward to launching sales in coming months.
The device, called Quell, is largely the same as the company's Sensus device, which was first approved by the U.S. Food and Drug Administration in 2012 for use by patients with chronic pain due to diabetes, sciatica, fibromyalgia, and degenerative knee conditions. That device, which uses electrical stimulation to raise levels…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Don Seiffert Source Type: news
More News: Chronic Pain | Diabetes | Endocrinology | Fibromyalgia | Food and Drug Administration (FDA) | Health | Health Management | Neurology | Pain | Pharmaceuticals | Sciatica